VK

Vijay Kumar Gupta Kambampourambil

Active Director Designated Partner DIN 08985992
DIN 08985992 First appointment Dec 2020 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Vijay Kumar Gupta Kambampourambil

Data last updated:

Vijay Kumar Gupta Kambampourambil is a Designated Partner at Pharmedz Labs Llp (since 2020). The company operates in Pharma.

DIN 08985992
Primary Designation Designated Partner
Industry Pharma
First Appointment 07 Dec 2020
Oldest Company Age 9 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner07 Dec 20202017Active

Board colleagues of Vijay Kumar Gupta Kambampourambil

NameDINCompanyDesignation
Murali Narayana Rao Kurapati08407796Pharmedz Labs LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Pharmedz Labs Llp
Premium access

Shareholding and investment profile for Vijay Kumar Gupta Kambampourambil

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vijay Kumar Gupta Kambampourambil

Vijay Kumar Gupta Kambampourambil currently holds 1 directorship: Pharmedz Labs Llp (Designated Partner, since 07 Dec 2020).

Vijay Kumar Gupta Kambampourambil was first appointed on 07 Dec 2020 as Designated Partner at Pharmedz Labs Llp.

The current boards of Vijay Kumar Gupta Kambampourambil's companies include Murali Narayana Rao Kurapati (Pharmedz Labs Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available